Table 13.
Riluzole | ||||||
---|---|---|---|---|---|---|
Admission | 90 days | |||||
A | B | C | D | E | ||
Grade | N=27 | N (%) | N (%) | N (%) | N (%) | N (%) |
A | 12 | 6 (50) | 3 (25) | 2 (17) | 1 (8) | |
B | 8 | 1 (13) | 3 (37) | 4 (50) | ||
C | 7 | 1 (14) | 5 (72) | 1 (14) |
Registry | ||||||
---|---|---|---|---|---|---|
Admission | 90 days | |||||
A | B | C | D | E | ||
Grade | N=26 | N (%) | N (%) | N (%) | N (%) | N (%) |
A | 12 | 9 (75) | 1 (8) | 1 (8) | 1 (8) | |
B | 8 | 4 (50) | 3 (38) | 1 (12) | ||
C | 6 | 3 (50) | 3 (50) |
Conversions of impairment grades at 90 days.